National Institutes of Health (NIH)

127 articles with National Institutes of Health (NIH)

• Scientists explore blood flow bump that happens when our neurons are significantly activated

  7/15/2019

  When a group of our neurons get activated by thinking hard about a math problem or the vibrant colors of an exotic flower, within a single second blood flow to those brain cells increases a bit.

• Lovelace Biomedical & Exemplar Genetics Win New Contract to Develop New Model of Sickle Cell Disease

  7/11/2019

  Lovelace Biomedical and Exemplar Genetics have teamed together to win a contract from the National Institutes of Health's National Center for the Advancement of Translational Sciences, for the study of Sickle Cell Disease.

• NIH Awards Grant to Enable Biosciences to Develop Improved Lyme Disease Test

  7/11/2019

  The Centers for Disease Control and Prevention (CDC) estimates that approximately 300,000 people will be infected with Lyme disease each year in the United States.

• 

  Scripps Research Snags $129 Million for HIV Vaccine Investigation

  7/11/2019

  The goal of the research is to develop a treatment that will spur the immune system into producing antibodies capable of disarming numerous strains of HIV.

• IDT Biologika Awarded with a Task Order Within 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases

  7/10/2019

  IDT Biologika announced that the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, an agency of the United States Department of Health and Human Services, has awarded the company a new Task Order within the 10-year Indefinite Delivery, Indefinite Quantity contract no.

• Day Zero Diagnostics Awarded NIH Funding for Technology to Improve the Speed and Accuracy of Detecting Hospital-Acquired Infections

  7/10/2019

  SBIR Phase I funding supports development of algorithm for analyzing whole genome sequencing data in seconds

• The declining impact of federal funding on cancer innovation

  7/9/2019

  The National Cancer Institute (NCI), an independent institute of the National Institutes of Health (NIH), was established in 1937 to provide for, foster and coordinate research relating to cancer.

• Cognition Therapeutics Receives $3.3 Million NIA Grant to Conduct qEEG Study of Elayta™ with World-Leading Alzheimer’s Biomarker Experts

  7/9/2019

  Investigating Quantitative EEG as Biomarker of Patient Response to Treatment in Future Efficacy Studies

• MedicaSafe Receives $1.0 million Grant from National Institutes of Health

  7/9/2019

  Funding to support ongoing clinical trials for drug-device combination technology to improve clinical insight and compliance in patients with opioid addiction

• Lovelace Biomedical Leads Team to Help the NIH Fight Rare Diseases

  7/2/2019

  The National Institute of Health awarded contract aims to help find ways to treat rare diseases

• Tiziana Life Science reports Independent Third Party Article in New England Journal of Medicine on Intravenous Treatment with a Humanized Anti-CD3 mAb showing delays in progression of Type 1 Diabetes

  7/1/2019

  Independent third party Phase 2 results show Teplizumab, a mouse derived humanized anti-CD3 monoclonal antibody (mAb) significantly slowed progression of Type 1 diabetes in high risk population

• MDNA55 Shows Promising Results in Models of Ovarian Cancer

  6/26/2019

  Scientists at the NIH and FDA Demonstrate Impressive Synergy of MDNA55 with Interferons

• Halozyme Announces CRADA With National Institute of Allergy and Infectious Diseases For Use Of ENHANZE® Drug Delivery Technology

  6/25/2019

  NIAID to Study Use of ENHANZE® Technology with Broadly Neutralizing Antibodies for Development of New HIV Treatments

• Versiti Blood Research Institute awarded $13M research grant

  6/20/2019

  NIH award advances Versiti's research into von Willebrand disease

• Cancer Research Innovator Dr. Donald Berry Joins OTraces' Scientific Advisory Board to Advance Early Cancer Detection

  6/19/2019

  OTraces' Diagnostics Capabilities Also Include Minimal Residual Disease Detection and Cancer Progression and Surveillance Blood Testing

• Parental Support Is Key When Autistic Adolescents Want to Learn to Drive

  6/18/2019

  Specialized driving instructors stress life skill development, parent-supervised practice, and individualized training to enhance learning and independence

• Retrophin Announces Cooperative Research and Development Agreement with NCATS and the Alagille Syndrome Alliance to Identify Potential Therapeutics for Alagille Syndrome

  6/18/2019

  Retrophin, Inc. announced that it has entered into a three-way Cooperative Research and Development Agreement with the National Institutes of Health’s National Center for Advancing Translational Sciences and patient advocacy foundation Alagille Syndrome Alliance to collaborate on research efforts aimed at the identification and development of potentially novel therapeutics for Alagille syndrome.

• Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology

  6/9/2019

  Significant Time-in-Range Improvements Demonstrated in Adult and Pediatric Age Groups

• TrialNet Announces Type 1 Diabetes Prevention Breakthrough--

  6/9/2019

  Immunotherapy delays diagnosis in people at high risk

• A Single Course of Provention's PRV-031 (Teplizumab) Delays Type 1 Diabetes Onset in High-Risk Individuals by at Least Two Years

  6/9/2019

  Results from the NIH-Sponsored "At-Risk" Study Published in The New England Journal of Medicine and Presented at the American Diabetes Association Annual Meeting